Black Diamond Therapeutics (BDTX) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.25
0.16
0.57
0.98

Details

Expected EPS
-0.184444
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+13.25%

Description

⁨Black Diamond Therapeutics⁩ (⁦BDTX⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts